ArticleNew directions for evaluation2022
Advice from local/site evaluators: How to manage "up" within a large-scale initiative.
Article in New directions for evaluation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
BUilding Infrastructure Leading to Diversity (BUILD), an initiative of the National Institutes of Health (NIH), provides grants to undergraduate institutions to implement and study innovative approaches to engaging and retaining students from diverse backgrounds in biomedical research. The NIH awarded BUILD grants to 10 higher education institutions in multiple states, including funding for local evaluations. This chapter presents findings from an online survey and interviews with 15 local evaluators from nine of the 10 BUILD sites. Participants shared their perspectives on the role of professional local evaluators in national evaluations, ideal national-local multisite evaluation partnerships, and the ways that funders can support these partnerships to maximize impact. They argued for customized technical assistance and other support for local evaluations; the importance of including local results in national evaluation findings; the value of local evaluators' subject-matter expertise; and the potential for funders to act as central organizing entities in national-local evaluation partnerships.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.